protein aggregation inhibitors (Advanced Life Sciences)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameprotein aggregation inhibitors (Advanced Life Sciences)
Drug Alias NameALS-633ALS-499
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsDiabetes Mellitus, Type 2Alzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArgonne National Laboratory
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Alzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A